Nitric oxide is fundamental to neurovascular coupling in humans
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Key points: Preclinical models have demonstrated that nitric oxide is a key component of neurovascular coupling; this has yet to be translated to humans. We conducted two separate protocols utilizing intravenous infusion of a nitric oxide synthase inhibitor and isovolumic haemodilution to assess the influence of nitric oxide on neurovascular coupling in humans. Isovolumic haemodilution did not alter neurovascular coupling. Intravenous infusion of a nitric oxide synthase inhibitor reduced the neurovascular coupling response by ∼30%, indicating that nitric oxide is integral to neurovascular coupling in humans. Nitric oxide is a vital neurovascular signalling molecule in preclinical models, yet the mechanisms underlying neurovascular coupling (NVC) in humans have yet to be elucidated. To investigate the contribution of nitric oxide to NVC in humans, we utilized a visual stimulus paradigm to elicit an NVC response in the posterior cerebral circulation. Two distinct mechanistic interventions were conducted on young healthy males: (1) NVC was assessed during intravenous infusion of saline (placebo) and the non‐selective competitive nitric oxide synthase inhibitor NG‐monomethyl‐l‐arginine (l‐NMMA, 5 mg kg−1 bolus & subsequent 50 μg kg−1 min−1 maintenance dose; n = 10). The order of infusion was randomized, counterbalanced and single blinded. A subset of participants in this study (n = 4) underwent a separate intervention with phenylephrine infusion to independently consider the influence of blood pressure changes on NVC (0.1–0.6 μg kg−1 min−1 constant infusion). (2) NVC was assessed prior to and following isovolumic haemodilution, whereby 20% of whole blood was removed and replaced with 5% human serum albumin to reduce haemoglobin concentration (n = 8). For both protocols, arterial and internal jugular venous blood samples were collected at rest and coupled with volumetric measures of cerebral blood flow (duplex ultrasound) to quantify resting cerebral metabolic parameters. l‐NMMA elicited a 30% reduction in the peak (P = 0.01), but not average (P = 0.11), NVC response. Neither phenylephrine nor haemodilution influenced NVC. Nitric oxide signalling is integral to NVC in humans, providing a new direction for research into pharmacological treatment of humans with dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566 · cited 2×
“Indeed, <5% of pre-clinically discovered ‘targets’ translate to successful drug development (Paul et al. 2010; Collins, 2011; Dirnagl et al. 2013).”
BackgroundThe nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2466 · Cited by 2,739 · cited 2×
“Given that NO similarly upregulates cGMP, that NO is targetable from a therapeutic standpoint in humans (Lundberg et al. 2008) and that NO has now been demonstrated as a key regulator of NVC in humans, further investigation should seek to determine how modulation of NO signalling influences NVC in normal ageing and pa…”
BackgroundGlial and neuronal control of brain blood flow
Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., MacVicar, B. A., & Newman, E. A. (2010) · Nature · doi:10.1038/nature09613 · Cited by 2,511 · cited 11×
“1) (Attwell et al. 2010); however, in accordance with the work of Lindauer et al.”
BackgroundResultInfluentialThe Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
Capillary pericytes regulate cerebral blood flow in health and disease
Hall, C. N., Reynell, C., Gesslein, B., Hamilton, N. B., Mishra, A., Sutherland, B. A., O’Farrell, F. M., Buchan, A. M., Lauritzen, M., & Attwell, D. (2014) · Nature · doi:10.1038/nature13165 · Cited by 1,870 · cited 2×
“2017), 20-hydroxyeicosatetraenoic acid (Sun et al. 2000; Hall et al. 2014) and prostaglandins (reviewed by Attwell et al.”
BackgroundIturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11934 · Cited by 1,202 · cited 2×
“That the observed effect of NO is integral to human NVC, coupled with the role of accelerated cerebral hypoperfusion in the development of cerebrovascular diseases such as Alzhiemer’s disease (Iturria-Medina et al. 2016), highlights the applicability of NO as a potential therapeutic target.”
BackgroundBlood Flow Regulation by S -Nitrosohemoglobin in the Physiological Oxygen Gradient
Stamler, J. S., Jia, L., Eu, J. P., McMahon, T. J., Demchenko, I. T., Bonaventura, J., Gernert, K., & Piantadosi, C. A. (1997) · Science · doi:10.1126/science.276.5321.2034 · Cited by 1,050 · cited 10×
“Second, as the erythrocyte mediates NO transport and release (Stamler et al. 1997; Gladwin et al. 2006) we placed additional focus on this mechanism by conducting an isovolumic haemodilution protocol to reduce haemoglobin concentration.”
BackgroundMethodInfluentialAmyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes
Nortley, R., Korte, N., Izquierdo, P., Hirunpattarasilp, C., Mishra, A., Jaunmuktane, Z., Kyrargyri, V., Pfeiffer, T., Khennouf, L., Madry, C., et al. (2019) · Science · doi:10.1126/science.aav9518 · Cited by 682
Lauer, T., Preik, M., Rassaf, T., Strauer, B. E., Deussen, A., Feelisch, M., & Kelm, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221381098 · Cited by 585 · cited 2×
“…for compensatory redundancies to mitigate the impact of NOS inhibition (Phillips et al. 2016) and/or only a partial blockade of NO synthesis in the current study (Stamler et al. 1994; Lauer et al. 2001) – both factors that would indicate the effect observed herein is perhaps an underestimation.”
BackgroundCapillary K+-sensing initiates retrograde hyperpolarization to increase local cerebral blood flow
Longden, T. A., Dabertrand, F., Koide, M., Gonzales, A. L., Tykocki, N. R., Brayden, J. E., Hill-Eubanks, D., & Nelson, M. T. (2017) · Nature Neuroscience · doi:10.1038/nn.4533 · Cited by 522
Cited by
Nitric oxide signaling in health and disease
Lundberg, J. O., & Weitzberg, E. (2022) · Cell · doi:10.1016/j.cell.2022.06.010 · Cited by 826
Revisiting the neurovascular unit
Schaeffer, S., & Iadecola, C. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00904-7 · Cited by 649
Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs
Cirino, G., Szabo, C., & Papapetropoulos, A. (2023) · Physiological Reviews · doi:10.1152/physrev.00028.2021 · Cited by 553
Lourenço, C. F., & Laranjinha, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.729201 · Cited by 85
Neuronal nitric oxide synthase regulates regional brain perfusion in healthy humans
O’Gallagher, K., Puledda, F., O’Daly, O., Ryan, M., Dancy, L., Chowienczyk, P. J., Zelaya, F., Goadsby, P. J., & Shah, A. M. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab155 · Cited by 39
“31 However, a study that investigated the effects of L-NMMA on increases in CBF evoked by finger movement found no effect of the NOS inhibitor.”
Gonçalves, J. S., Marçal, A. L., Marques, B. S., Costa, F. D., Laranjinha, J., Rocha, B. S., & Lourenço, C. F. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230491 · Cited by 6
Metadata
- Authors
- Hoiland, R. L., Caldwell, H. G., Howe, C. A., Nowak‐Flück, D., Stacey, B. S., Bailey, D. M., Paton, J. F. R., Green, D. J., Sekhon, M. S., Macleod, D. B., & Ainslie, P. N.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2020-08-31
- Volume
- 598
- Issue
- 21
- Pages
- 4927-4939
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W3048397571
- Cited by
- 74
- References
- 11
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.